# K103741: Surgisure Tissue Removal System

- Pathway: 510(k) (Traditional)
- Applicant: Interlace Medical, Inc.
- Decided: Mar 2, 2011 after 69 days
- Product code: GCJ (Laparoscope, General & Plastic Surgery)
- Device class: 2
- Regulation: 21 CFR 876.1500
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K953695 (1995). 14 ancestors in all.
No later device cites it as a predicate yet.
1 of 15 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K091100: Myosure Hysteroscopic Tissue Removal System, Interlace Medical, Inc. (2009) Summary page 1.
- K100559: Myosure Hysteroscopic Tissue Removal System, Interlace Medical, Inc. (2010) Summary page 1.
- K050639: Lumenis Versacut Tissue Morcellator System, Lumenis, Inc. (2005) Summary page 1.

## Indications for use
The SurgiSure Tissue Removal System is intended for use under direct or endoscopic visualization for the morcellation and removal of dissected tissue during pelviscopic, laparoscopic, percutaneous and open surgical procedures whenever access to the surgical site is limited.

Source page: https://510kreport.com/device/K103741
Methodology: https://510kreport.com/methodology